Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.

Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT.

Aliment Pharmacol Ther. 2003 Mar 15;17(6):827-34.

2.

Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.

Langagergaard V, Pedersen L, Gislum M, Nørgard B, Sørensen HT.

Aliment Pharmacol Ther. 2007 Jan 1;25(1):73-81.

4.

The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.

Nørgård B, Pedersen L, Jacobsen J, Rasmussen SN, Sørensen HT.

Aliment Pharmacol Ther. 2004 Mar 15;19(6):679-85.

5.

Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.

Nørgård B, Pedersen L, Christensen LA, Sørensen HT.

Am J Gastroenterol. 2007 Jul;102(7):1406-13. Epub 2007 Apr 16.

PMID:
17437503
6.

Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.

Nørgård B, Fonager K, Pedersen L, Jacobsen BA, Sørensen HT.

Gut. 2003 Feb;52(2):243-7.

7.

Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study.

Ratanajamit C, Vinther Skriver M, Jepsen P, Chongsuvivatwong V, Olsen J, Sørensen HT.

Scand J Infect Dis. 2003;35(4):255-9.

PMID:
12839155
8.

Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.

Ratanajamit C, Skriver MV, Nørgaard M, Jepsen P, Schønheyder HC, Sørensen HT.

J Antimicrob Chemother. 2003 Nov;52(5):837-41. Epub 2003 Sep 30.

PMID:
14519675
9.

Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.

Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT.

J Antimicrob Chemother. 2008 Jul;62(1):172-6. doi: 10.1093/jac/dkn157. Epub 2008 Apr 9.

PMID:
18400803
10.

A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark.

Jepsen P, Skriver MV, Floyd A, Lipworth L, Schønheyder HC, Sørensen HT.

Br J Clin Pharmacol. 2003 Feb;55(2):216-21.

11.

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

Wogelius P, Nørgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Lipworth L, Sørensen HT.

Epidemiology. 2006 Nov;17(6):701-4.

PMID:
17028507
12.

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Coelho J, Beaugerie L, Colombel JF, Hébuterne X, Lerebours E, Lémann M, Baumer P, Cosnes J, Bourreille A, Gendre JP, Seksik P, Blain A, Metman EH, Nisard A, Cadiot G, Veyrac M, Coffin B, Dray X, Carrat F, Marteau P; CESAME Pregnancy Study Group (France).

Gut. 2011 Feb;60(2):198-203. doi: 10.1136/gut.2010.222893. Epub 2010 Nov 29.

PMID:
21115547
13.

Birth outcomes in women exposed to anticonvulsant drugs.

Fonager K, Larsen H, Pedersen L, Sørensen HT.

Acta Neurol Scand. 2000 May;101(5):289-94.

PMID:
10987315
14.

Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero.

Dencker BB, Larsen H, Jensen ES, Schønheyder HC, Nielsen GL, Sørensen HT.

Clin Microbiol Infect. 2002 Apr;8(4):196-201.

15.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
16.

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.

Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH.

Gastroenterology. 2003 Jan;124(1):9-17.

PMID:
12512024
17.

Birth outcomes in pregnant women treated with low-molecular-weight heparin.

Sørensen HT, Johnsen SP, Larsen H, Pedersen L, Nielsen GL, Møller M.

Acta Obstet Gynecol Scand. 2000 Aug;79(8):655-9.

PMID:
10949230
18.

Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.

Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.

Am J Gastroenterol. 2010 Sep;105(9):2003-8. doi: 10.1038/ajg.2010.138. Epub 2010 Aug 10.

PMID:
20700117
19.

Birth outcome and risk of neonatal hypoglycaemia following in utero exposure to pivmecillinam: a population-based cohort study with 414 exposed pregnancies.

Larsen H, Nielsen GL, Møller M, Ebbesen F, Schønheyder HC, Sørensen HT.

Scand J Infect Dis. 2001;33(6):439-44.

PMID:
11450863
20.

The safety of proton pump inhibitors in pregnancy.

Nielsen GL, Sørensen HT, Thulstrup AM, Tage-Jensen U, Olesen C, Ekbom A.

Aliment Pharmacol Ther. 1999 Aug;13(8):1085-9.

Supplemental Content

Support Center